A recent study that focused on the migratory and metastatic potential of cancer cells showed that knockdown or chemical inhibition of eEF2K led to reduced integrin expression and decreased migration and invasion both in vitro and in vivo (Xie et al., 2018). Here, EEF2K is linked to cancer.